Stereotactic body radiotherapy for solitary spine metastasis

6Citations
Citations of this article
30Readers
Mendeley users who have this article in their library.

Abstract

A clear consensus has not been established regarding the best treatment for solitary bone metastasis. Here, we reviewed the medical records of patients with a controlled primary malignancy who had only solitary spine metastasis without metastasis to the extraspinal bone or viscera and underwent treatment between April 2007 and December 2012 with stereotactic body radiosurgery using CyberKnife, with a total dose of 24 Gy in three to four fractions. During that time, there were only four cases. This was effective in each case, and all the four patients had no local failure and remained alive at a median follow-up of 68 months (range, 64 to 80 months). Although our experience is limited, this study suggests that stereotactic body radiotherapy could be a feasible, safe, effective, and noninvasive alternative treatment for solitary spine metastasis in patients who are medically inoperable or unsuitable for surgery. © 2013. The Korean Society for Radiation Oncology.

Cite

CITATION STYLE

APA

Lee, S., Chun, M., & Lee, M. J. (2013). Stereotactic body radiotherapy for solitary spine metastasis. Radiation Oncology Journal, 31(4), 260–266. https://doi.org/10.3857/roj.2013.31.4.260

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free